Endometriosis is associated with aberrant metabolite profiles in plasma

A diagnostic model based on acylcarnitines can predict the presence and stage of endometriosis.

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Published
Like Comment

Volume 107, Issue 3, Pages 699–706

Authors:

Sophia Letsiou, Ph.D., Dirkje P. Peterse, M.Sc., Amelie Fassbender, Ph.D., Margriet M. Hendriks, Ph.D., Niels J. van den Broek, B.Sc., Rudolf Berger, M.D., Dorien F. O, M.Sc., Arne Vanhie, M.D., Alexandra Vodolazkaia, M.D., Ph.D., Anne Van Langendonckt, M.D., Ph.D., Jacques Donnez, M.D., Ph.D., Amy C. Harms, Ph.D., Rob J. Vreeken, Ph.D., Patrick G. Groothuis, Ph.D., Marie-Madeleine Dolmans, M.D., Ph.D., Arjan B. Brenkman, Ph.D., Thomas M. D'Hooghe, M.D., Ph.D.

Abstract:

A diagnostic model based on acylcarnitines has the potential to predict the presence and stage of endometriosis.


Read the full text here.

Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.